According to documents submitted to the U.S. Securities and Exchange Commission (SEC), West Pharmaceutical Services Inc. has disclosed the details of its relevant agreement terms.

The document shows that these agreements set an initial term of ten years. Notably, the agreements include early termination clauses. Under two specific circumstances, the agreements can be terminated before the ten-year period expires: first, by mutual consent of both parties; second, in the event of a change in the company’s control. This disclosure provides investors with further information regarding the stability of the company’s long-term contract arrangements, clarifying the key conditions that may affect the continuity of the agreements.